These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Possible mechanisms of inhibitory effects of atherosclerosis and lipoproteins on EDRF]. Hirata K; Akita H; Inoue N; Matsuda Y; Yokoyama M Jpn Circ J; 1992; 56 Suppl 5():1308-13. PubMed ID: 1291714 [No Abstract] [Full Text] [Related]
15. [Pathogenesis of atherosclerosis in the 21st century (review of the literature)]. Titov VN Klin Lab Diagn; 1998 Jan; (1):3-11. PubMed ID: 9532889 [No Abstract] [Full Text] [Related]
16. Is atherosclerosis reversible? Gotto AM J Am Diet Assoc; 1979 May; 74(5):551-7. PubMed ID: 374453 [TBL] [Abstract][Full Text] [Related]
17. Lipoproteins and the pathogenesis of atherosclerosis. Steinberg D Circulation; 1987 Sep; 76(3):508-14. PubMed ID: 3621517 [TBL] [Abstract][Full Text] [Related]
18. Endothelium-derived relaxing factor (nitric oxide), lipoprotein oxidation and atherosclerosis. Bruckdorfer KR; Jacobs M; Rice-Evans C Biochem Soc Trans; 1990 Dec; 18(6):1061-3. PubMed ID: 2088806 [No Abstract] [Full Text] [Related]